Grace Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GRCE

Comments

Grace Therapeutics Inc Earnings Estimates

GRCENASDAQ

Trade with Public

$4.29

0.174.13%

At close: Feb 27, 4:00 PM EST

$4.35

0.05851.36%

After Hours: Feb 27, 5:52 PM EST

Overview NewsEarningsOptions Analyst Ratings Short Interest Stock Report

Grace Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GRCE

In the most recent quarter (Q3), Grace Therapeutics reported EPS of $-0.14, beating estimates of $-0.27 by 0.48%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Grace Therapeutics has beaten EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Grace Therapeutics has averaged an EPS surprise of 0.73% and a revenue surprise of 0.00%.

Earnings Date

Feb 12

EPS

$-0.140

Quarterly Revenue

$0.00

Annual Revenue
(as of Dec 31)

–

Grace Therapeutics Earnings History

Analyze the earnings history of Grace Therapeutics using advanced sorting and filters.

Grace Therapeutics (GRCE) Earnings Per Share

The chart below shows Grace Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Grace Therapeutics (GRCE) Revenue

The chart below shows Grace Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?

Grace Therapeutics (GRCE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2026 for Q3.

What were the latest earnings per share (EPS) for Grace Therapeutics (NASDAQ:GRCE)?

Grace Therapeutics (GRCE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2026 for Q3 and the Actual EPS was $-0.14, which beat the estimate of $-0.27.

What were Grace Therapeutics’s (NASDAQ:GRCE) revenues?

Grace Therapeutics (GRCE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2026 for Q3 and the Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Cumberland Pharmaceuticals Inc

NASDAQ:CPIX

$4.92

Rani Therapeutics Holdings Inc

Incannex Healthcare Inc

Telomir Pharmaceuticals Inc

Grace Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GRCE

In the most recent quarter (Q3), Grace Therapeutics reported EPS of $-0.14, beating estimates of $-0.27 by 0.48%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Grace Therapeutics has beaten EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Grace Therapeutics has averaged an EPS surprise of 0.73% and a revenue surprise of 0.00%.

Earnings Date

Feb 12

EPS

$-0.140

Quarterly Revenue

$0.00

Annual Revenue
(as of Dec 31)

–

Grace Therapeutics Earnings History

Analyze the earnings history of Grace Therapeutics using advanced sorting and filters.

												Get Alert
GRCE	Grace Therapeutics	Q3	-$0.36	-$0.27	-$0.14	48.15%	$0.00	—	$0.00	—	02/12/2026	Get Alert
GRCE	Grace Therapeutics	Q2	-$0.30	-$0.25	-$0.06	76.00%	$0.00	—	$0.00	—	11/13/2025	Get Alert
GRCE	Grace Therapeutics	Q1	—	-$0.31	-$0.21	32.26%	—	—	$0.00	—	08/12/2025	Get Alert
GRCE	Grace Therapeutics	Q4	—	-$0.29	$0.10	134.48%	—	—	$0.00	—	06/23/2025	Get Alert
GRCE	Grace Therapeutics	Q3	-$0.21	-$0.34	-$0.36	-5.88%	—	—	$0.00	—	02/13/2025	Get Alert
GRCE	Grace Therapeutics	Q2	-$0.43	—	-$0.30	—	—	—	$0.00	—	11/13/2024	Get Alert

Grace Therapeutics (GRCE) Earnings Per Share

The chart below shows Grace Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	2026-02-12	$-0.14	$-0.27	48.1 %
Q2	2025-11-13	$-0.06	$-0.25	76.0 %
Q1	2025-08-12	$-0.21	$-0.31	32.3 %
Q4	2025-06-23	$0.10	$-0.29	134.5 %

Grace Therapeutics (GRCE) Revenue

The chart below shows Grace Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?

Grace Therapeutics (GRCE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2026 for Q3.